cGxP.wire https://validator.w3.org/feed/docs/rss2.html Autonomix Expands Patent Protection for Nerve Therapy CRISPR Therapeutics Advances Zugo-cel in Autoimmune Disease JCR and Italfarmaco Expand Global Hunter Syndrome Deal Biogen Litifilimab Shows Durable CLE Benefits Teknova and Pluristyx File FDA DMF for PluriFreeze Lilly and Jaypirca Expand CLL/SLL Treatment Options Banner Capital Agrees to Acquire Three Plastics Companies Marengo Reports Phase 2 Invikafusp Alfa Trial Data Bristol Myers Squibb Launches Champions in Care Movement Quotient Sciences and Acesion Advance AI Formulation Daiichi Sankyo and AstraZeneca Partner With Summit on Datroway Verastem Reports New RAMP 201 Data in Recurrent LGSOC Johnson & Johnson Reports Two-Year Icotrokinra Psoriasis Data Candel Reports 24.5-Month Survival in NSCLC Study SeaStar Medical Gains New AKI Billing Codes Akari Therapeutics Expands PH1 ADC Patent Portfolio Lundbeck Advances Movement Disorder Pipeline With New Data ViroMissile Advances IDOV-2 Phase I Trial After First Cohort Ascletis Reports Promising Weight-Loss Data for ASC36_35FDC Nexalin Technology Expands Commercial Push in South America C ASE Bioscience Joins $7.3M ARPA-H Cell Therapy Program Spectral AI Initiates DeepView Clinical Study for Burn Label Expansion Legend Biotech Launches ELITE Grant Program for CAR-T Innovation Cerapedics PearlMatrix Gains Medicare New Technology Payment Vima Therapeutics Presents New Research in Movement Disorders Imbed Biosciences Registers DualGuard Matrix Safety Study Lilly’s Foundayo Shows Lower Predicted Diabetes and Heart Risk Ceribell Wins FDA Clearance for Advanced EEG Monitoring MavriX Bio Gains FDA Rare Pediatric Disease Designation SK pharmteco Expands U.S. Small Molecule, Peptide Capacity AIM ImmunoTech Advances Ampligen Strategy in Pancreatic Cancer Genentech Reports Positive Phase III evERA Results for Giredestrant Roswell Park and Generate Launch GB-5267 CAR T Trial BioCardia Files Revised FDA De Novo Submission for Helix Amplio Pharma Reports Positive NovoBioJect Phase 1b Data Trethera Gains FDA Fast Track for TRE-515 in NSCLC Regeneron Advances Ubamatamab in LGSOC Arvinas to Present ARV-102 Biomarker Data in Parkinson’s Disease Inspire Medical Systems Announces New CPT Codes for Inspire V Cullinan Initiates FDA NDA Submission for Zipalertinib Agomab Reports Positive STENOVA OLE Data for Ontunisertib BiomEdit Receives USDA License for Poultry Biologic VertigoDx Gains FDA Clearance for SmartVertigo System Pierre Fabre Resubmits Tabelecleucel BLA to FDA Shattuck Labs Advances SL-325 in Hidradenitis Suppurativa Monte Rosa Reports Positive Phase 1 MRT-8102 Results Genentech Reports Real-World Vabysmo Data Across Retinal Diseases Pfizer Reports Phase 2 Tilrekimig Data in Atopic Dermatitis Regeneron Reports Phase 2 Trevogrumab COURAGE Data Neurocrine Advances Prader-Willi Syndrome Research